Pay in 4 interest-free payments of $5.43 Learn more
Ships within 48 hours · Estimated delivery Oct 26 - Oct 31
Phase 2: Published in the New England Journal of Medicine
GLP-1 drugs aren't just about the number on the scale
Joint pain, or arthralgia, is not listed among the common adverse effects in the FDA-approved prescribing information for semaglutide formulations
In studies on people using semaglutide, some users experienced up to 10-15% reduction in body weight within six months to a year of treatment
Groups 4 and 5 (semaglutide 1.0 mg and 2.4 mg, respectively) discontinued placebo infusions
The MHRA Summary of Product Characteristics (SmPC) for Wegovy lists fatigue as a common side effect
US$ 26.75
US$ 27.02
US$ 22.30
US$ 22.95
